- Las Vegas Sands (LVS) to outperform from neutral at Credit Suisse.
- Boston Scientific (BSX) to outperform from sector perform at RBC Capital.
- Windstream (WIN) to buy from hold at Citigroup.
- Expeditors (EXPD) to buy from neutral at UBS.
- A123 Systems (AONE) to neutral from underperform and Chesapeake Midstream (CHKM) to buy from neutral at BofA/Merrill.
- AvalonBay (AVB) to outperform from neutral and Post Properties (PPS) to neutral from underperform at Cowen.
BSX posts
FeedAnalyst Calls: AONE, AVB, BSX, LVS, MDRX, RRC, SAP, TIVO, WIN ...
Continue reading Analyst Calls: AONE, AVB, BSX, LVS, MDRX, RRC, SAP, TIVO, WIN ...
Analyst Calls: FDX, HSY, IACI, FSLR, AON ...
- FedEx (FDX) and Concur Tech (CNQR) to outperform from neutral at RW Baird.
- Hershey (HSY) to outperform from neutral at Credit Suisse.
- Open Text (OTEX) to outperform from sector perform at RBC Capital.
- Bemis (BMS) and Hudson Pacific (HPP) upgraded to buy from hold at KeyBanc.
- InterActiveCorp (IACI) to buy from neutral at BofA/Merrill.
- KB Home (KBH) to neutral from sell at Goldman.
- News Corp. (NWSA) to neutral from underperform at Cowen.
Continue reading Analyst Calls: FDX, HSY, IACI, FSLR, AON ...
Analyst Calls: AA, BA, BP, BSX, COH, GM, INTC, NSM, STJ, TIF, TSN, UA ...
- Boeing (BA) to overweight from neutral at JPMorgan.
- Alcoa (AA) to buy from hold at Deutsche Bank.
- BP (BP) to outperform from market perform at Raymond James.
- Office Depot (ODP) and Staples (SPLS) to buy from neutral at Janney Capital.
- ON Semiconductor (ONNN) to buy from hold at Citigroup.
- Kennametal (KMT) and Polyone (POL) to buy from hold at KeyBanc.
- Airgas (ARG) to outperform from market perform at William Blair.
- EchoStar (SATS) to neutral from underperform at Macquarie.
Continue reading Analyst Calls: AA, BA, BP, BSX, COH, GM, INTC, NSM, STJ, TIF, TSN, UA ...
Analyst Calls: AAPL, AMGN, BIIB, BSX, CHK, DVN, EOG, GRMN, PHM, WPO ...
- Goldman upgraded Jones Lang LaSalle (JLL) to buy from neutral.
- Credit Suisse upgraded Pulte Group (PHM) to neutral from underperform. Note that Citigroup downgraded the stock.
- Ameristar Casinos (ASCA) was upgraded to neutral from sell at Merriman.
- Citigroup upgraded Kimco Realty (KIM) to hold from sell.
- Mistras (MG) was upgraded to buy from hold at KeyBanc.
- Devon Energy (DVN) was upgraded to outperform from neutral at Macquarie.
- Garmin (GRMN) was upgraded to outperform from sector perform at PacCrest.
Continue reading Analyst Calls: AAPL, AMGN, BIIB, BSX, CHK, DVN, EOG, GRMN, PHM, WPO ...
Analyst Calls: BSX, FORM, HPQ, JACK, MCO, NFLX, PPL, RTP, VALE ...
- JMP Securities upgraded Hewlett-Packard (HPQ) to outperform from market perform based on valuation and checks that indicate strength in enterprise PCs, high growth geographies and light laptops. The firm has a $50 target on the stock.
- RBC Capital upgraded Rio Tinto (RTP) to outperform from sector perform, citing the company's improving growth plans and attractive risk profile.
- Goldman upgraded FormFactor (FORM) to neutral from sell, but lowered its price target to $6 from $10. The firm cites valuation for the upgrade.
- MCG Capital (MCGC) was upgraded to outperform from market perform at FBR Capital.
- CRH (CRH) was upgraded to neutral from underweight at JPMorgan.
- Melco Crown (MPEL) was upgraded to overweight from equal weight at Morgan Stanley.
Continue reading Analyst Calls: BSX, FORM, HPQ, JACK, MCO, NFLX, PPL, RTP, VALE ...
Should You Avoid Medtronic?
Medical technology company Medtronic (MDT), whose colleagues include Boston Scientific (BSX) and Johnson & Johnson (JNJ), has not had a good year. The chart communicates a very bearish situation. But when a stock takes a significant dip, many investors wonder if it is time to buy.Earlier in the week, the business reported disappointing fiscal first-quarter news. If that wasn't enough, UBS issued a downgrade on the shares. The firm has reduced the equity's status to neutral from buy, according to BloggingStocks' analyst calls article. The price target is $33. Medtronic finished Thursday's session at a quote of $32.28.
Analyst Calls: AOSL, BIDU, BSX, BTU, CHCO, EVVV, NXST, POT, PUK, RST, WEN ...
- UBS upgraded Potash (POT) to buy from neutral and raised its price target to $112 from $106. UBS raised its 2011 potash production estimates based on expectations for a tighter market and notes the potential for China to import substantial amounts of corn.
- BMO Capital upgraded Peabody Energy (BTU) to outperform from market perform. The firm, which has a $49 target on the stock, cites valuation for the upgrade.
- Janney Montgomery upgraded City Holding (CHCO) to buy from neutral with a $37 price target, citing the recent pullback in shares.
- Boston Scientific (BSX) was upgraded to sell from conviction sell at Goldman.
- Pegasystems (PEGA) was upgraded to buy from hold at Roth Capital.
- Wendy's/Arby's (WEN) was upgraded to buy from neutral at SunTrust.
Continue reading Analyst Calls: AOSL, BIDU, BSX, BTU, CHCO, EVVV, NXST, POT, PUK, RST, WEN ...
Closing Bell: From Flash-Crash to Flash Dance (BSX, CSCO, MS, GS, BIDU, HBAN, NBG)
Trade deficits, record government budget deficits... Humbug! Today was a day where bad news did not matter in the broader sense. Overseas markets were up, but the U.S. was where the action was. Here were the unofficial closing bell levels:
Dow 10,896.91 +148.65 (1.38%)
S&P 500 1,171.67 +15.88 (1.37%)
Nasdaq 2,425.02 +49.71 (2.09%)
Top Analyst Calls
Continue reading Closing Bell: From Flash-Crash to Flash Dance (BSX, CSCO, MS, GS, BIDU, HBAN, NBG)
Analyst Calls: BBY, CAT, EMC, EXPE, FCX, ICE, NTAP, PCE, STJ, VRTX ...
- Jefferies upgraded St. Jude (STJ) to buy from hold and raised its target to $49 from $39. The firm cites valuation and the positive impact from the Boston Scientific (BSX) ICD recall for the upgrade. Shares were also upgraded to neutral from sell at Goldman, as the firm sees upside for shares into Q1 results.
- RBC Capital upgraded EMC Corp. (EMC) to outperform from sector perform and raised its target to $22 from $21. The firm upgraded shares based on valuation and believes the company can meet or modestly beat March quarter expectations.
- Auriga upgraded MetroPCS (PCS) to buy from hold as it believes customer migration away from postpaid to prepaid may be accelerating. The firm raised its target for shares to $9 from $7.
- Caterpillar (CAT) was raised to outperform from neutral at Baird.
- Best Buy (BBY) was upgraded to market perform from underperform at FBR Capital.
- Expedia (EXPE) was upgraded to overweight from neutral at Piper Jaffray.
Continue reading Analyst Calls: BBY, CAT, EMC, EXPE, FCX, ICE, NTAP, PCE, STJ, VRTX ...
Boston Scientific to Pull Defibrillators
Boston Scientific (BSX) announced Monday it is recalling of all of its implantable heart defibrillators as it didn't notify regulators of manufacturing changes. The company stated that the safety of patients was never in question and it doesn't believe that doctors need to remove the defibrillators from patients. The manufacturing changes are being described as a "documentation problem," and the company said it is working with the Food and Drug Administration to get the problem fixed. Following the news, the stock fell 12.6% to close at $6.80. According to the report, defibrillators made up 15% of BSX's U.S. revenue a year ago. Furthermore, the company stated that this news could have a "material impact" on 2010 earnings.
Analyst Upgrades, Downgrades and Initiations: ANF, ELON, MMM, NVDA, SLAB, SNI ...
- Oppenheimer upgraded Abercrombie & Fitch (ANF) to outperform from perform as it finds the risk/reward on shares attractive and believes the company's Q4 results and easing comparisons could serve as positive catalysts. The firm set a $46 price target on shares.
- Bernstein upgraded 3M Company (MMM) to outperform from market perform based on expectations the company will continue to beat and raise guidance and that the organic growth rate will continue to improve. The firm raised its target to $99 from $90.
- Roth Capital expects Nvidia (NVDA) to benefit from its new GPU platform Fermi in Q1, resulting in a PC business recovery. Additionally, the firm, which upgraded shares to buy from hold and has a $21 target, expects Nvidia to offset Intel (INTC) declines by selling low-end GPUs compatible with Intel's Pinetrail and Westmere platforms.
- Syngenta (SYT) was upgraded to buy from hold at Collins Stewart.
- Cameron (CAM) was raised to overweight from neutral at HSBC.
- Sigma-Aldrich (SIAL) was lifted to outperform from neutral at Baird.
Continue reading Analyst Upgrades, Downgrades and Initiations: ANF, ELON, MMM, NVDA, SLAB, SNI ...
Boston Scientific to Pay Johnson & Johnson $1.7B Settlement
Boston Scientific (BSX - option chain) stock is trading lower today the company reached an agreement with Johnson & Johnson (JNJ) to settle three patent disputes. Under the deal, BSX will pay JNJ $1.725 billion. If you think this stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on BSX.This morning, BSX opened at $8.48. So far today the stock has hit a high of $8.83 and a low of $8.24. As of 11:50, BSX is trading at $8.47, down 16 cents (-1.8%). The chart for BSX looks bullish and S&P gives BSX a positive 4 STARS (out of 5) buy ranking.
Continue reading Boston Scientific to Pay Johnson & Johnson $1.7B Settlement
Analyst Upgrades, Downgrades and Initiations: ADS, CL, DWA, MON, MS, SBUX, WFC ...
- FBR Capital upgraded Wells Fargo (WFC) to market perform from underperform and raised its target on shares to $26 from $21 following the company's better-than-expected quarter.
- Deutsche Bank upgraded Starbucks (SBUX) to buy from hold following the company's better-than-expected Q1 results. The firm raised its target price on shares to $30 from $19.
- UBS upgraded Dreamworks (DWA) to buy from neutral, citing upside from its upcoming film releases. The firm raised its target to $50 from $35.
- Colgate (CL) was upgraded to conviction buy from buy at Goldman.
- F5 Networks (FFIV) was upgraded to buy from neutral at BofA/Merrill.
- Applied Industrial (AIT) was upgraded to overweight from equal weight at Stephens.
Continue reading Analyst Upgrades, Downgrades and Initiations: ADS, CL, DWA, MON, MS, SBUX, WFC ...
Analyst Upgrades, Downgrades and Initiations: BA, BMY, EAT, INTC, MS, UNH, WYNN ...
- Baird upgraded Intel (INTC) to outperform from neutral and has a $26 target on the stock. The firm's checks indicate tier-one PC OEMs have raised their 1H10 procurement forecasts, which could lead to Intel outperformance.
- Citigroup upgraded UnitedHealth (UNH) to buy from hold on expectations the company will benefit from a sector rotation into Managed Care in 2010. The firm raised its price target on shares to $39 from $30.
- UBS upgraded Morgan Stanley (MS) to buy from neutral based on strong capital and liquidity positions, building investment banking pipelines, and expectations for a turn in EPS/ROE, among other reasons.
- Deutsche Bank upgraded the U.S. Refining group as it believes demand is improving and margins could expand in 2010. The firm raised its rating on Sunoco (SUN) to hold from sell and its target on shares to $25 from $18, and upgraded Tesoro (TSO) and Frontier Oil (FTO) to buy from hold.
- Boeing (BA) was raised to overweight from equal weight at Barclays.
- Wynn Resorts (WYNN) was upgraded at UBS to buy from neutral.
- Investors Bancorp (ISBC) was upgraded to buy from neutral at Janney Montgomery.
Continue reading Analyst Upgrades, Downgrades and Initiations: BA, BMY, EAT, INTC, MS, UNH, WYNN ...
Health Insurers Get Brief Relief on Proposed Tax
Insurance companies just bought themselves a year. Claiming that a proposed tax on health insurance would force them to charge higher premiums, carriers were able to convince senators to defer this particular measure for a year.
This comes as a benefit to UnitedHealth Group (UNH), WellPoint (WLP) and smaller companies writing health insurance policies. Manufacturers of medical devices have won some relief, as well, though the drug business didn't. An earlier plan to tax cosmetic medical procedures was also scrapped.
Continue reading Health Insurers Get Brief Relief on Proposed Tax
Savings Experiment: Snow Removal
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger





